Dr. Maja Babic, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1735 27th St, Waller Building, Suite 206, Portsmouth, OH 45662 Phone: 740-355-9240 Fax: 740-355-9281 |
News Archive
NeuroVasx, Inc., a medical device company that develops technologies for the treatment of hemorrhagic and ischemic stroke, announced today that the first procedure in Spain utilizing its cPAX Aneurysm Treatment System was performed in Madrid. cPAX received CE Mark earlier this year.
Inaccessible workplaces, normative departmental cultures and 'ableist' academic systems have all contributed to the continued underrepresentation and exclusion of disabled researchers in the Geosciences, according to an article published today (Thursday 8 June) in Nature Geosciences.
Twenty-six percent (26%) of black Americans (BA) with chronic hepatitis C who received treatment with Pegasys plus Copegus (peginterferon alfa-2a plus ribavirin) achieved a sustained virological response (SVR), according to study results published in the June 2004 issue of Hepatology.
According to new research in the U.S. most of the experts giving advice on the diagnosis and management of mental illness have had financial links to drug makers such as research funding or stock holdings.
› Verified 3 days ago